Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-17
1994-01-11
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514212, 5142282, 5142335, 514255, 514318, 514324, 514337, 514422, 514432, 514456, 540596, 544 62, 544151, 544145, 544376, 546193, 546196, 546202, 546269, 546274, 548525, 549 23, 549400, 549401, C07D40112, C07D41312, C07D41712, C07D40312, A61K 31445, A61K 3154, A61K 3155, A61K 3140
Patent
active
052781747
ABSTRACT:
Sigma binding site agents having the formula ##STR1## which are useful to inhibit sigma binding site-induced activity, pharmaceutical compositions including these agents, and methods of using these agents to inhibit sigma binding site-induced activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented agents.
REFERENCES:
patent: 3810896 (1974-05-01), Witte et al.
patent: 3835175 (1974-09-01), Carpino et al.
patent: 3906031 (1975-09-01), Carpino et al.
patent: 4376123 (1983-04-01), Hausberg et al.
patent: 4394519 (1983-07-01), Carpino et al.
patent: 4678787 (1987-07-01), Jaeu
patent: 4780478 (1988-10-01), Hausberg et al.
patent: 4797498 (1989-01-01), Albrecht et al.
patent: 4900727 (1990-02-01), Kattige et al.
Ji et al. "Synthesis of isoflavones as cardiovascular drugs" Yaoxue Xuebao 24 906-12 (1989).
Razdan et al. "Substituted 4-chromanones" CA 79:126312 (1973).
Wu et al. "Flavones 2. Synthesis and Structure-Activity Relationship" J. Med. Chem 32 183-192 (1989).
Hackh's Dictionary p. 27 Fourth Edition (1972).
Jesthi, P. K. et al., J. Indian Chem. Society (1965) vol. 42, pp. 105-108.
Chouinard, G. and Annable, L., Psychopharmacol. (1984), vol. 84, pp. 282-284.
Klosa, V. J., J. Park. Chem. (1963), vol. 22, p. 359.
Bayer, E. and Kramer, B., Chem. Ber. (1964), vol. 97, pp. 1057-1068.
Szegi, J. et al., Congr. Hung. Pharmacol. Soc. [Proc.] (1971), p. 221.
Hetenyi, E. L. et al., Acta Pharm. Hung. (1974), vol. 44, p. 1.
Da Re et al., J. Med. Chem. (1972), vol. 15, No. 8, pp. 868-869.
Briggs, M. T. et al., J. Chem. Res. Synop. (1982), p. 242.
Chem. Abstracts, 99:139772 (1983).
Chem. Abstracts, 94:65430 (1981).
Chem. Abstracts, 63:9918c-9921d. (1965).
Chem. Abstracts, 104:50791 (1986).
Martin, W. R. et al., J. Pharm. Exp. Ther., vol. 197, No. 3 (1976), pp. 517-532.
Chem. Abs., vol. 60, No. 5441d, 1963 (Feb. 17, 1964).
Erickson Ronald H.
Natalie, Jr. Kenneth J.
Pontecorvo Michael J.
Rzeszotarski Waclaw J.
Chang Celia
Rotman Alan L.
Scios Nova Inc.
LandOfFree
Sigma binding site agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sigma binding site agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sigma binding site agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1631566